Acetylcholinesterase inhibitors: a patent review (2008 - present)
- PMID: 22768972
- DOI: 10.1517/13543776.2012.701620
Acetylcholinesterase inhibitors: a patent review (2008 - present)
Abstract
Introduction: Both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are present in the body in large amounts. AChE is an important part of the cholinergic nervous system taking place in the central and peripheral nervous system. AChE is a target of several toxins such as insecticide carbofuran, nerve agents, sarin, soman, tabun and VX. Beside toxins, drugs for treatment of Alzheimer's disease and myasthenia gravis, such as galantamine, donepezil, rivastigmine, tacrine, huperzine, pyridostigmine and neostigmine, are known.
Areas covered: The review gives an overview of the importance of the cholinergic nervous system, the biochemistry of AChE and the role of AChE inhibitors. Current efforts to introduce potent drugs for Alzheimer's disease therapy and reduce toxicity, while keeping the maximal pharmacological effect, are also discussed.
Expert opinion: The current research effort into AChE inhibitors can be divided into two categories. First, new toxins useful for agricultural purposes and second, novel drugs that need to be prepared, although there is less interest in the new toxins. The research for drugs for Alzheimer's disease needs to focus on inhibitors that reduce the deposition of amyloid plaques, but do not initiate AChE expression.
Similar articles
-
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).Expert Opin Ther Pat. 2017 Apr;27(4):455-476. doi: 10.1080/13543776.2017.1272571. Epub 2017 Jan 17. Expert Opin Ther Pat. 2017. PMID: 27967267 Review.
-
Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.Eur J Med Chem. 2013;70:165-88. doi: 10.1016/j.ejmech.2013.09.050. Epub 2013 Oct 6. Eur J Med Chem. 2013. PMID: 24148993 Review.
-
Cholinesterase inhibitors: a patent review (2007 - 2011).Expert Opin Ther Pat. 2012 Aug;22(8):853-69. doi: 10.1517/13543776.2012.701619. Epub 2012 Jul 6. Expert Opin Ther Pat. 2012. PMID: 22764681 Review.
-
Cholinesterases, a target of pharmacology and toxicology.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):219-29. doi: 10.5507/bp.2011.036. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22286807 Review.
-
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.Toxicology. 2007 Apr 20;233(1-3):60-9. doi: 10.1016/j.tox.2006.11.069. Epub 2006 Dec 2. Toxicology. 2007. PMID: 17194517
Cited by
-
Labdanum Resin from Cistus ladanifer L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity.Molecules. 2024 May 9;29(10):2222. doi: 10.3390/molecules29102222. Molecules. 2024. PMID: 38792084 Free PMC article.
-
Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B.J Cheminform. 2024 May 24;16(1):59. doi: 10.1186/s13321-024-00845-w. J Cheminform. 2024. PMID: 38790018 Free PMC article.
-
Citronellal as a Promising Candidate for Alzheimer's Disease Treatment: A Comprehensive Study on In Silico and In Vivo Anti-Acetylcholine Esterase Activity.Metabolites. 2023 Nov 4;13(11):1133. doi: 10.3390/metabo13111133. Metabolites. 2023. PMID: 37999229 Free PMC article.
-
New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength.Front Pharmacol. 2023 Aug 4;14:1227496. doi: 10.3389/fphar.2023.1227496. eCollection 2023. Front Pharmacol. 2023. PMID: 37601044 Free PMC article. Review.
-
Identification of potential inhibitors against Alzheimer-related proteins in Cordyceps militaris ethanol extract: experimental evidence and computational analyses.3 Biotech. 2023 Sep;13(9):292. doi: 10.1007/s13205-023-03714-9. Epub 2023 Aug 4. 3 Biotech. 2023. PMID: 37547918
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous